March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Get the basics on HIV transmission: how it is and is not spread, both common and rare types of transmission, and how to avoid getting HIV.
Learn about common, important ways to plan for the future care of your children: guardianship, standby guardianship, wills, and adoption.